CureZone   Log On   Join
Test shows SBO's eat tumors for dinner!!
 
finallyfaith Views: 17,929
Published: 15 years ago
Status:       RN [Message recommended for CureZone Newsletter!]
 

Test shows SBO's eat tumors for dinner!!


this is an amazing test done by mainstream medical experts which demonstrates that soil based organims (SBO's) can be injected directly into tumours where they consume the cancerous mass, they literally eat it for dinner!! i pulled out the quote about SBO's, the entire article follows. "soil bacterium" is of course another name fore SBO's. in the articles they also use the term "bugs" to describe SBO's, which is completely wrong, bacteria are not bugs and i have no idea why they use that term.

for those reading this on the Cancer Forum , you can check out the soil based organisms forum for more info.


"When they injected the soil bacterium Clostridium[ck] novyi into the bloodstream of mice with tumours, it spread throughout the necrotic region, consuming living tumour cells as well as dead tissue."

http://www.newscientist.com/channel/health/cancer/dn1610

Flesh-eating bugs become cancer killers
09:42 27 November 2001
From New Scientist Print Edition. Subscribe and get 4 free issues.
Philip Cohen, San Francisco

Anti-cancer drug development, Johns Hopkins
Proceedings of the National Academy of Sciences

Injecting flesh-eating bugs into people with cancer may sound crazy - but initial studies suggest the only danger is that they destroy tumours so fast that the body might not be able to cope with the remains.

The trick is to pick anaerobic bacteria that thrive in the oxygen-poor interior of fast-growing tumours, but die as they reach oxygen-rich healthy tissue.

"The exciting thing is we can combine this approach with chemotherapy and hit the tumour from both the inside and the outside," says Bert Vogelstein of Johns Hopkins School of Medicine in Baltimore, Maryland.

Tumours supply themselves with food and oxygen by growing blood vessels. But some tumours grow so rapidly their interiors become starved of blood and oxygen, and turn into "necrotic" regions full of dead and dying cells.

Surprisingly, this makes them more difficult to destroy. Drugs cannot reach the tissue at lethal doses because its blood supply is so poor, while radiation treatments depend on oxygen to trigger cell death. After treatment stops, surviving cells from the necrotic region can start dividing again.

All consuming
Cancer researchers have long realised that anaerobic bacteria could be used to attack the necrotic region without harming healthy tissue. But the microbes tested so far have left parts of tumours untouched. So Vogelstein's team widened the search, testing 26 strains of anaerobic bacteria.

When they injected the soil bacterium Clostridium[ck] novyi into the bloodstream of mice with tumours, it spread throughout the necrotic region, consuming living tumour cells as well as dead tissue.

"That was completely unexpected," says Vogelstein. "We thought we'd have to genetically engineer it to do that." However, the microbes perished near the edges of the tumour, leaving the job half done.

So the researchers tried combining the bugs with chemotherapy. "The tumour died so quickly, you could almost watch it," says Vogelstein. Out of eight animals given the combination treatment, the tumours shrank dramatically or disappeared completely in seven, and regrew only in one, the team reports in the Proceedings of the National Academy of Sciences.

"Combining these different approaches is a very clever move," says Rakesh Jain, a cancer researcher at Harvard Medical School in Boston. "It's wonderful work."

Global supply
The catch is that three of the eight mice died. But the researchers think this could be because the tumours were destroyed so quickly that the waste products flooded the animals' circulation.

In small animals these toxins spread too quickly to combat, but in humans they should not be lethal. "We'll need to go to larger animals to test that theory out," says Vogelstein.

He says it will probably be years before the therapy is ready for its clinical debut. But when the time comes, it will not be hard to stock up on the prolific microbe. "We can grow a world supply of it in my lab in one day," he says.
 

 
Printer-friendly version of this page Email this message to a friend

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2021  www.curezone.org

1.031 sec, (2)